NEW YORK (GenomeWeb News) - Fluorotechnics of Sydney, Australia, has agreed to acquire ETC Elektrophorese-Technik, a provider of DNA and protein electrophoresis consumables and equipment based in Kirchentellinsfurt, Germany.
Fluorotechnics said it will buy all of ETC’s issued shares in exchange for an undisclosed number of its own shares. The company did not disclose the financial value of the transaction.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.